Form D · Biotechnology
Spartan Bioscience Inc.
Nepean, A6 · CIK 0001463231
Offering snapshot reported Apr 3, 2013 · SEC filing
- Reported sold
- $24K Offering amount: $24K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Aug 17, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 3, 2013 | Initial | $24,000 | No comparison | 1 | SEC filing |
| May 16, 2012 | Initial | $110,000 | No comparison | 1 | SEC filing |
| May 4, 2009 | Initial | $150,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-194403
Source: Form D, filed Apr 3, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Abrams | Executive |
| Lawrence D'andrea | Director, Executive |
| Mark Houghting | Executive |
| Mark Kershey | Executive |
| John Lem | Director |
| Paul Lem | Director |
| Paul Markell | Executive |
| Ken Paige | Director |
| Alan Shayanpour | Executive |
| Jamie Spiegelman | Director |
| Jamie Spiegleman | Director |
| Michael Stork | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
6 Gurdwara Road
Nepean, A6, K2E8A3
Nepean, A6, K2E8A3